Group
Cytokine Modulators
Group Profile
| Therapeutic Class | Immunotherapy |
| Drug Class | Cytokine Modulators |
| Mechanism of Action | Macrophage activator |
| Drugs in group | CDX-301· Mifamurtide· Nogapendekin alfa inbakicept· Peginterferon Alfa-2b |
Study design
RT–Drug Timing Window
Study design
RT–Drug Timing Window
The data above refer to patients treated with Cytokine Modulators as the sole drug class,
excluding any concurrent use of drugs from other groups.
Combination therapy data are available in the section below.
Individual Drugs
Select a drug to view its individual evidence base (drug + SBRT, no other concurrent systemic drugs). Drugs without available data are shown greyed out.